Advocacy intelligence hub — real-time data for patient organizations
CSL Behring — PHASE3
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Browse all Rare hemorrhagic disorder due to a constitutional coagulation factors defect news →
View all Rare hemorrhagic disorder due to a constitutional coagulation factors defect specialists →